Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€4.10
04.10.22
-
04.10.23
14.15%
25.10.22

Probably not worthwhile Investment
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.65
18.09.22
-
18.09.23
-3.77%
01.10.22

Risky Investment
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.62
14.09.22
-
14.09.23
1.70%
17.09.22

Risky Investment
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.62
13.09.22
-
13.09.23
-37.10%
17.09.22

Could be very worthwhile Investment >20% year
buy
Crossject S.A.

Start price
Target price
Perf. (%)
€4.71
16.08.22
€5.00
16.08.23
-14.13%
12.11.22

Could be worthwhile Investment >10% per year
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.91
13.08.22
€1.00
13.08.23
-12.70%
23.08.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€3.72
07.08.22
-
07.08.23
-13.98%
26.08.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.24
24.06.22
€5.00
24.06.23
-1.57%
26.06.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.77
10.06.22
€0.20
10.06.23
24.58%
26.06.22

Valuable balance sheet
Probably not worthwhile Investment
very negative Cash Flow expected
Junk rating
buy
BioLase Inc.

Start price
Target price
Perf. (%)
€4.73
06.05.22
-
06.05.23
-96.11%
06.05.23

buy
Newegg Commerce Inc.

Start price
Target price
Perf. (%)
€5.95
02.05.22
€12.00
02.05.23
-25.71%
16.05.22

Could be very worthwhile Investment >20% year
buy
Newegg Commerce Inc.

Start price
Target price
Perf. (%)
€5.95
19.04.22
€11.00
19.04.23
0.00%
02.05.22

Could be very worthwhile Investment >20% year
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€3.16
09.04.22
-
09.04.23
0.00%
18.04.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Newegg Commerce Inc.

Start price
Target price
Perf. (%)
€6.95
07.04.22
-
07.04.23
-17.99%
14.04.22

Probably not worthwhile Investment
buy
Newegg Commerce Inc.

Start price
Target price
Perf. (%)
€6.20
05.04.22
€11.50
05.04.23
-4.03%
19.04.22

Could be very worthwhile Investment >20% year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€7.59
01.04.22
€12.50
01.04.23
-76.56%
04.03.23

Could be worthwhile Investment >10% per year
Vyant Bio Inc.

Start price
Target price
Perf. (%)
€8.50
30.03.22
-
30.03.23
-24.12%
31.03.22

Risky Investment
buy
PAVmed Inc

Start price
Target price
Perf. (%)
€1.35
21.03.22
€8.00
21.03.23
-14.92%
02.04.22

Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Revenue decline/stagnation expected
PAVmed Inc

Start price
Target price
Perf. (%)
€1.41
20.03.22
-
20.03.23
-80.13%
21.03.23

Probably not worthwhile Investment
buy
Visiomed Group

Start price
Target price
Perf. (%)
€0.17
24.01.22
-
24.01.23
116.40%
25.01.23

Could be worthwhile Investment >10% per year
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€6.00
17.01.22
-
17.01.23
-44.67%
22.01.22

Risky Investment
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€4.14
09.01.22
-
09.01.23
-5.80%
23.01.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Euromedis Groupe

Start price
Target price
Perf. (%)
€10.64
24.12.21
-
24.12.22
-57.99%
25.12.22

Could be worthwhile Investment >10% per year
buy
Maternus-Kliniken AG

Start price
Target price
Perf. (%)
€4.74
23.12.21
-
23.12.22
-50.21%
25.08.22

buy
Craneware plc

Start price
Target price
Perf. (%)
€27.40
07.12.21
€32.00
07.12.22
-13.14%
07.12.22

Could be worthwhile Investment >10% per year
Innovative
Some uniques
Future proof or reliable business model